Cagrilintide
Cagrilintide
Cagrilintide is a synthetic peptide that acts as an amylin analog. It is being investigated for its potential use in the treatment of obesity and type 2 diabetes. Cagrilintide is designed to mimic the effects of the naturally occurring hormone amylin, which is co-secreted with insulin by the pancreatic beta cells.
Mechanism of Action[edit]
Cagrilintide works by mimicking the action of amylin, a hormone that helps regulate blood glucose levels and suppress appetite. Amylin slows gastric emptying, reduces postprandial glucagon secretion, and promotes satiety. By acting as an amylin analog, cagrilintide can help control blood sugar levels and reduce food intake, which may aid in weight loss and improve glycemic control in individuals with type 2 diabetes.
Clinical Development[edit]
Cagrilintide is currently undergoing clinical trials to evaluate its safety and efficacy. It is being studied both as a monotherapy and in combination with other antidiabetic agents. The results of these trials will determine its potential role in the management of obesity and type 2 diabetes.
Potential Benefits[edit]
The potential benefits of cagrilintide include improved glycemic control, weight loss, and reduced risk of cardiovascular complications associated with obesity and type 2 diabetes. By enhancing the effects of amylin, cagrilintide may offer a novel therapeutic option for patients who are unable to achieve adequate control with existing treatments.
Side Effects[edit]
As with any medication, cagrilintide may have side effects. Common side effects observed in clinical trials include nausea, vomiting, and decreased appetite. The safety profile of cagrilintide is still being evaluated, and further studies are needed to fully understand its long-term effects.
Related Pages[edit]
This peptide related article is a stub. You can help WikiMD by expanding it.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
